Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1823]
News [2730]
Articles [202]
Editorials [1]
Conferences [136]
elearning [13]
A 'one-two punch' to wipe out cancerous ovarian cells
A 'one-two punch' to wipe out cancerous ovarian cells
FDA approves pembrolizumab for first-line treatment of head and neck squamous cell carcinoma
FDA approves pembrolizumab for first-line treatment of head and neck squamous cell carcinoma
FDA approves polatuzumab vedotin-piiq for diffuse large B-cell lymphoma
FDA approves polatuzumab vedotin-piiq for diffuse large B-cell lymphoma
Long exposure to protein inhibitor may be key to more effective chemotherapy for cancer
Long exposure to protein inhibitor may be key to more effective chemotherapy for cancer
A molecular glue to overcome cancer drug resistance?
A molecular glue to overcome cancer drug resistance?
Radio-wave therapy proves effective against liver cancer cells
Radio-wave therapy proves effective against liver cancer cells
ASCO 2019: A tool to predict response to chemotherapy before bladder cancer surgery
ASCO 2019: A tool to predict response to chemotherapy before bladder cancer surgery
ASCO 2019: Patients who received PBI without chemotherapy experienced less fatigue, slightly poorer cosmesis
ASCO 2019: Patients who received PBI without chemotherapy experienced less fatigue, slightly poorer cosmesis
ASCO 2019: New standard regimen for women with uterine carcinosarcomas
ASCO 2019: New standard regimen for women with uterine carcinosarcomas
ASCO 2019: Suggested benefit in PCV chemoradiotherapy for both IDH-mutant WHO-defined molecular subgroups
ASCO 2019: Suggested benefit in PCV chemoradiotherapy for both IDH-mutant WHO-defined molecular subgroups

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation